Prescription drug information can be displayed online, so the price is...

Pharmaceutical Network November 16th revealed the drug network transaction monitoring! Some non-compliant enterprises have been written off on November 12, the State Drug Administration hung up the "drug network sales supervision and management measures (draft for comments)" (hereinafter referred to as "draft for comments"), in addition to the industry has been looking forward to a long time "with the network sales of prescription drug conditions of drug retail enterprises, can show the public prescription drug information", there is also a "bright spot" - drug network transaction monitoring clear refinement.
Reporters from the national drug network trading monitoring platform construction project of the Southern Institute network information monitoring center was informed that the platform has been officially launched in April this year, and to the national drug regulatory authorities at all levels to transfer illegal clues, there are now some illegal enterprises have been written off or included in the list of operating anomalies.
Prescription drug monitoring normalization of the content of the "request for comments draft" on prescription drug online sales, compared with the previous round of public consultation draft, this "request for comments draft" on prescription drug online sales subject qualification requirements, sales process requirements, retention of record materials and displayable information have given clear guidance.
" needs to pay special attention to the draft not only emphasizes 'ensuring that the source of electronic prescriptions is true and reliable' but also requires drug retailers to sell prescription drugs online, and should also submit supporting materials to ensure that the source of electronic prescriptions is true and reliable.
ma Guanglei, deputy secretary-general of the China Pharmaceutical Business Association, who has participated in the consideration of relevant documents on many occasions, pointed out that the "Draft for Comments" on the practical level of the various subjects involved in drug network sales should be responsible, as well as the content of each regulatory body responsible for the supervision of the means, systems, etc. have done nothing, quite enforceable and landing.
, the submission requirements for supporting material effectively address the need for clear parts of subsequent implementation, and it is foreseeable that monitoring and penalties will become the norm.
, the state drug regulator has long been in place to target online sales of drugs.
it was revealed that as early as the end of 2018, the Southern Institute was commissioned by the State Drug Administration Drug Supervision Department to guide the completion of the "National Drug Network Monitoring System" construction work, and completed the construction and docking of various types of regulatory databases, in 2019 has been put into trial operation.
, the General Division of the State Drug Administration issued the Notice on the Implementation of the National Drug Network Transaction Monitoring System, which was officially launched.
Southern Institute network information monitoring center Wu Jie told reporters that from the current monitoring of the situation, in the discovery of illegal violations of the clues in nearly 30% of the B2C transactions on a third-party platform illegal sales of prescription drugs, including undocumented operations, merchants do not sell prescription drugs without a prescription (no need to upload prescriptions can be directly purchased, upload prescription links are false, OTC tied prescription drugs, hanging sheep head selling dog meat, etc.), the sale of special management categories of prescription drugs (such as qumado, can be treated, bots, etc.).
Or affected by the above factors, the Draft for Comments separately set out a chapter, a total of 9 articles to clarify the third-party platform should fulfill the obligations, such as the application for entry of the drug network seller qualification review, the establishment of inspection system, the preservation of drug display information, transaction records, sales vouchers, evaluation and complaint reporting information (the period of preservation should not be less than 3 years, and not less than 1 year after the expiration date of the drug) and so on.
industry pointed out that there are detailed hard conditions for follow-up supervision and implementation of more feasible, the formal introduction of the method, the third-party platform of drug network sales will inevitably move towards standardization.
how to deal with 360-degree full coverage? According to the division of labor in the Draft for Comments, the State Drug Administration organized the establishment of a national drug network trading monitoring platform.
the provincial drug supervision and administration department establishes its own drug network trading monitoring platform, it shall realize data docking with the national drug network trading monitoring platform.
at or above the county level shall, in accordance with its duties, organize timely investigation and disposal of the illegal and illegal activities found in the monitoring.
It is understood that since the official launch of the national drug network trading monitoring platform in April, has opened more than 500 accounts, through 31 provinces and more than 400 cities, vertical three-level linkage, horizontal solution of cross-regional clues, to achieve monitoring and disposal of online sales supervision closed-loop traceable management.
Wu Jie revealed that the current national drug network trading monitoring platform has covered the PC-side web page (WEB), mobile applications (APP), social platforms (forums, WeChat, microblogs, etc.), small programs, search engines, etc. ;
varieties monitored in addition to all kinds of drugs already on the domestic market, but also a variety of undocumented drugs, foreign drugs, hospital preparations and so on.
Combined with the overall requirements and work deployment of the State Drug Administration's 2020 drug network sales violations and special corrective actions, the monitoring platform has transferred the clues of violations and violations to drug regulatory departments at all levels throughout the country, providing a strong technical support for the supervision of drug online sales.
Local regulatory authorities on the basis of clues for further investigation and verification, the illegal enterprises involved in the interview, order rectification, some of which have been written off or included in the list of operating anomalies, or file a case and a fine, closed the website, closed the web page or off the shelves of drugs.
industry sources point out that in the face of applications based on big data analytics technology, as well as 360-degree tracking of drug trace information and online transaction trace information monitoring, the best and safest response is to comply with the regulations, online prescription sales of prescription drugs, or to ensure that the source of electronic prescriptions sold online prescription drugs is true and reliable.
fact, this rapid growth in "Internet plus" medical services now has a relatively stable foundation accumulation.
From the executive level, as long as it is a legitimate and compliant prescription issued by medical institutions, including the embedding of the doctor's electronic signature during the consultation process, can file all kinds of medical records in the patient's medical procedures into electronic documents stamped with digital signatures and time stamps, to ensure authenticity, security, tamper-proof are true and reliable sources of electronic prescriptions.
in the senior pharmaceutical Internet experts, drug empowerment CEO Yu Qing, the current Internet hospital prescriptions can be in the short term to meet the needs of prescription drug online sales.
, of course, the irregular part will be phased out as the policy lands.
" he stressed that the discussion of many years of drug network sales policy landing, clarity of direction will promote more pharmaceutical companies and platforms to participate in the development of related industries.
。